These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 12177271)

  • 41. Two distinct cellular mechanisms of osteoclast formation and bone resorption in periprosthetic osteolysis.
    Sabokbar A; Kudo O; Athanasou NA
    J Orthop Res; 2003 Jan; 21(1):73-80. PubMed ID: 12507582
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Scutellarin inhibits RANKL-mediated osteoclastogenesis and titanium particle-induced osteolysis via suppression of NF-κB and MAPK signaling pathway.
    Zhao S; Sun Y; Li X; Wang J; Yan L; Zhang Z; Wang D; Dai J; He J; Wang S
    Int Immunopharmacol; 2016 Nov; 40():458-465. PubMed ID: 27728897
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Erythromycin inhibits wear debris-induced inflammatory osteolysis in a murine model.
    Ren W; Wu B; Peng X; Mayton L; Yu D; Ren J; Chen BD; Wooley PH
    J Orthop Res; 2006 Feb; 24(2):280-90. PubMed ID: 16435361
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Erythromycin inhibits wear debris-induced osteoclastogenesis by modulation of murine macrophage NF-kappaB activity.
    Ren W; Li XH; Chen BD; Wooley PH
    J Orthop Res; 2004 Jan; 22(1):21-9. PubMed ID: 14656655
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumor necrosis factor-alpha/nuclear transcription factor-kappaB signaling in periprosthetic osteolysis.
    Schwarz EM; Lu AP; Goater JJ; Benz EB; Kollias G; Rosier RN; Puzas JE; O'Keefe RJ
    J Orthop Res; 2000 May; 18(3):472-80. PubMed ID: 10937636
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of polyethylene and TiAlV wear particles on expression of RANK, RANKL and OPG mRNA.
    Baumann B; Rader CP; Seufert J; Nöth U; Rolf O; Eulert J; Jakob F
    Acta Orthop Scand; 2004 Jun; 75(3):295-302. PubMed ID: 15260421
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Age of donor alters the effect of cyclic hydrostatic pressure on production by human macrophages and osteoblasts of sRANKL, OPG and RANK.
    Evans CE; Mylchreest S; Andrew JG
    BMC Musculoskelet Disord; 2006 Mar; 7():21. PubMed ID: 16519799
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Utilizing minimally purified secreted rAAV for rapid and cost-effective manipulation of gene expression in the CNS.
    Goodwin MS; Croft CL; Futch HS; Ryu D; Ceballos-Diaz C; Liu X; Paterno G; Mejia C; Deng D; Menezes K; Londono L; Arjona K; Parianos M; Truong V; Rostonics E; Hernandez A; Boye SL; Boye SE; Levites Y; Cruz PE; Golde TE
    Mol Neurodegener; 2020 Mar; 15(1):15. PubMed ID: 32122372
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells.
    Kondo H; Guo J; Bringhurst FR
    J Bone Miner Res; 2002 Sep; 17(9):1667-79. PubMed ID: 12211438
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapeutic potentials of naringin on polymethylmethacrylate induced osteoclastogenesis and osteolysis, in vitro and in vivo assessments.
    Li N; Xu Z; Wooley PH; Zhang J; Yang SY
    Drug Des Devel Ther; 2014; 8():1-11. PubMed ID: 24376342
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation.
    Lee SK; Lorenzo JA
    Endocrinology; 1999 Aug; 140(8):3552-61. PubMed ID: 10433211
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Strontium ranelate inhibits titanium-particle-induced osteolysis by restraining inflammatory osteoclastogenesis in vivo.
    Liu X; Zhu S; Cui J; Shao H; Zhang W; Yang H; Xu Y; Geng D; Yu L
    Acta Biomater; 2014 Nov; 10(11):4912-4918. PubMed ID: 25078426
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Melatonin attenuates titanium particle-induced osteolysis via activation of Wnt/β-catenin signaling pathway.
    Ping Z; Hu X; Wang L; Shi J; Tao Y; Wu X; Hou Z; Guo X; Zhang W; Yang H; Xu Y; Wang Z; Geng D
    Acta Biomater; 2017 Mar; 51():513-525. PubMed ID: 28088671
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of titanium-particle-induced inflammatory osteolysis after local administration of dopamine and suppression of osteoclastogenesis via D2-like receptor signaling pathway.
    Yang H; Xu Y; Zhu M; Gu Y; Zhang W; Shao H; Wang Y; Ping Z; Hu X; Wang L; Geng D
    Biomaterials; 2016 Feb; 80():1-10. PubMed ID: 26695376
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapeutic relevance of osteoprotegerin gene therapy in osteosarcoma: blockade of the vicious cycle between tumor cell proliferation and bone resorption.
    Lamoureux F; Richard P; Wittrant Y; Battaglia S; Pilet P; Trichet V; Blanchard F; Gouin F; Pitard B; Heymann D; Redini F
    Cancer Res; 2007 Aug; 67(15):7308-18. PubMed ID: 17671200
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interleukin-4 cellular gene therapy and osteoprotegerin decrease inflammation-associated bone resorption in collagen-induced arthritis.
    Saidenberg-Kermanac'h N; Bessis N; Lemeiter D; de Vernejoul MC; Boissier MC; Cohen-Solal M
    J Clin Immunol; 2004 Jul; 24(4):370-8. PubMed ID: 15163893
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Myricetin prevents titanium particle-induced osteolysis in vivo and inhibits RANKL-induced osteoclastogenesis in vitro.
    Wu C; Wang W; Tian B; Liu X; Qu X; Zhai Z; Li H; Liu F; Fan Q; Tang T; Qin A; Zhu Z
    Biochem Pharmacol; 2015 Jan; 93(1):59-71. PubMed ID: 25449599
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.
    Udagawa N; Takahashi N; Yasuda H; Mizuno A; Itoh K; Ueno Y; Shinki T; Gillespie MT; Martin TJ; Higashio K; Suda T
    Endocrinology; 2000 Sep; 141(9):3478-84. PubMed ID: 10965921
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PTH differentially regulates expression of RANKL and OPG.
    Huang JC; Sakata T; Pfleger LL; Bencsik M; Halloran BP; Bikle DD; Nissenson RA
    J Bone Miner Res; 2004 Feb; 19(2):235-44. PubMed ID: 14969393
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MiR-106b inhibition suppresses inflammatory bone destruction of wear debris-induced periprosthetic osteolysis in rats.
    Yu B; Bai J; Shi J; Shen J; Guo X; Liu Y; Ge G; Lin J; Tao Y; Yang H; Xu Y; Qu Q; Geng D
    J Cell Mol Med; 2020 Jul; 24(13):7490-7503. PubMed ID: 32485091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.